Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
DJ Innate Pharma Is Maintained at Market Perform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
March 19, 2021 06:30 ET (10:30 GMT)
DJ Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
March 19, 2021 06:30 ET (10:30 GMT)
DJ Innate Pharma Is Maintained at Market Perform by SVB Leerink
DJ Innate Pharma在SVB Leerink的市场演出中保持不变
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 19, 2021 06:30 ET (10:30 GMT)
2021年3月19日东部时间06:30(格林尼治标准时间10:30)
DJ Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink
DJ先天医药目标价被SVB Leerink从每股5.00美元上调至7.00美元
Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/IPHA/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 19, 2021 06:30 ET (10:30 GMT)
2021年3月19日东部时间06:30(格林尼治标准时间10:30)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧